Advertisement

Index by author

February 01, 1982; Volume 220,Issue 2

A

  1. Adamski, S W

    1. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
      C M Prasad, S W Adamski, E Svensjö and G J Grega
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 293-298;

  2. Allison, M E

    1. Effects of bromocriptine on single nephron and whole-kidney function in rats.
      C T Stier, E A Cowden and M E Allison
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 366-370;

  3. Anderson, G F

    1. Evidence for a prostaglandin link in the purinergic activation of rabbit bladder smooth muscle.
      G F Anderson
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 347-352;

  4. Aronoff, G R

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

B

  1. Baker, S P

    1. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
      S P Baker and J Pitha
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 247-251;

  2. Bashour, F A

    1. Regional renal and splanchnic blood flows during nicotine infusion: effects of alpha and of combined alpha and beta adrenergic blockade.
      H F Downey, G J Crystal and F A Bashour
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 375-381;

  3. Bass, P

    1. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
      G W Gullikson, M Sender and P Bass
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 236-242;

  4. Beek, D

    1. A quantitative analysis of histamine H2-receptor-mediated relaxation of rabbit trachea.
      T P Kenakin and D Beek
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 353-357;

  5. Berkowitz, B A

    1. Characterization of vasopressin analgesia.
      B A Berkowitz and S Sherman
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 329-334;

  6. Bhargava, H N

    1. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
      H N Bhargava and H S Kim
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 394-398;

  7. Bianchini, P

    1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
      P Bianchini, B Osima, B Parma, H B Nader and C P Dietrich
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 406-410;

  8. Bigelow, G E

    1. Human cigarette smoking: manipulation of number of puffs per bout, interbout interval and nicotine dose.
      R R Griffiths, J E Henningfield and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 256-265;

  9. Blackburn, P

    1. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
      N F Tabachnik, P Blackburn, C M Peterson and A Cerami
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 243-246;

  10. Bothwell, W

    1. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
      W Bothwell, M Verburg, M Wynalda, E G Daniels and F A Fitzpatrick
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 229-235;

C

  1. Cayen, M N

    1. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.
      E S Ferdinandi, M N Cayen and C Pace-Asciak
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 417-426;

  2. Cerami, A

    1. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
      N F Tabachnik, P Blackburn, C M Peterson and A Cerami
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 243-246;

  3. Cho, C

    1. Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat.
      K L Raheja, W G Linscheer, C Cho and D Mahany
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 427-432;

  4. Clouet, D H

    1. The effect of acute opioid administration on the phosphorylation of rat striatal synaptic membrane proteins.
      N Williams and D H Clouet
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 278-286;

  5. Connors, B A

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

  6. Cowden, E A

    1. Effects of bromocriptine on single nephron and whole-kidney function in rats.
      C T Stier, E A Cowden and M E Allison
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 366-370;

  7. Crystal, G J

    1. Regional renal and splanchnic blood flows during nicotine infusion: effects of alpha and of combined alpha and beta adrenergic blockade.
      H F Downey, G J Crystal and F A Bashour
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 375-381;

D

  1. Daniels, E G

    1. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
      W Bothwell, M Verburg, M Wynalda, E G Daniels and F A Fitzpatrick
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 229-235;

  2. Dietrich, C P

    1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
      P Bianchini, B Osima, B Parma, H B Nader and C P Dietrich
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 406-410;

  3. Downey, H F

    1. Regional renal and splanchnic blood flows during nicotine infusion: effects of alpha and of combined alpha and beta adrenergic blockade.
      H F Downey, G J Crystal and F A Bashour
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 375-381;

E

  1. Elharrar, V

    1. Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.
      V Elharrar and D P Zipes
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 440-447;

  2. Ellingboe, J

    1. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
      J H Mendelson, J Ellingboe, N K Mello and J Kuehnle
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 252-255;

  3. Evan, A P

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

F

  1. Ferdinandi, E S

    1. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.
      E S Ferdinandi, M N Cayen and C Pace-Asciak
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 417-426;

  2. Fitzpatrick, F A

    1. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
      W Bothwell, M Verburg, M Wynalda, E G Daniels and F A Fitzpatrick
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 229-235;

  3. Fuller, R W

    1. Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms.
      R A Hahn, M D Hynes and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 389-393;

G

  1. Gerber, J G

    1. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins.
      M L Skoglund, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 371-374;

  2. Greenwell, A

    1. Relationship of tissue nonprotein/sulfhydryls to the acute toxic effects of 1,2-dibromo-3-chloropropane.
      W M Kluwe, A Greenwell and F Harrington
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 399-405;

  3. Grega, G J

    1. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
      C M Prasad, S W Adamski, E Svensjö and G J Grega
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 293-298;

  4. Griffiths, R R

    1. Human cigarette smoking: manipulation of number of puffs per bout, interbout interval and nicotine dose.
      R R Griffiths, J E Henningfield and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 256-265;

  5. Gullikson, G W

    1. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
      G W Gullikson, M Sender and P Bass
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 236-242;

H

  1. Hahn, R A

    1. Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms.
      R A Hahn, M D Hynes and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 389-393;

  2. Harrington, F

    1. Relationship of tissue nonprotein/sulfhydryls to the acute toxic effects of 1,2-dibromo-3-chloropropane.
      W M Kluwe, A Greenwell and F Harrington
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 399-405;

  3. Heckmann, M E

    1. Diethylstilbestrol: placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat.
      R K Miller, M E Heckmann and R C McKenzie
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 358-365;

  4. Henningfield, J E

    1. Human cigarette smoking: manipulation of number of puffs per bout, interbout interval and nicotine dose.
      R R Griffiths, J E Henningfield and G E Bigelow
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 256-265;

  5. Horita, A

    1. Interaction of apomorphine and stressors in the production of hyperthermia in the rabbit.
      A E Snow and A Horita
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 335-339;

  6. Howe, J R

    1. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
      J R Howe and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 311-321;

  7. Hurwitz, L

    1. Specific inhibition of calcium channels by calcium ions in smooth muscle.
      L Hurwitz, L J McGuffee, P M Smith and S A Little
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 382-388;

  8. Hynes, M D

    1. Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms.
      R A Hahn, M D Hynes and R W Fuller
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 389-393;

J

  1. Jope, R S

    1. Effects of phosphatidylcholine administration to rats on choline in blood and choline and acetylcholine in brain.
      R S Jope
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 322-328;

K

  1. Kajiyama, H

    1. Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol.
      Y Nomura, H Kajiyama and T Segawa
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 411-416;

  2. Kenakin, T P

    1. A quantitative analysis of histamine H2-receptor-mediated relaxation of rabbit trachea.
      T P Kenakin and D Beek
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 353-357;

  3. Kim, H S

    1. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
      H N Bhargava and H S Kim
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 394-398;

  4. Klaassen, C D

    1. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
      J B Watkins and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 305-310;

  5. Kleit, S A

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

  6. Kluwe, W M

    1. Relationship of tissue nonprotein/sulfhydryls to the acute toxic effects of 1,2-dibromo-3-chloropropane.
      W M Kluwe, A Greenwell and F Harrington
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 399-405;

  7. Kuehnle, J

    1. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
      J H Mendelson, J Ellingboe, N K Mello and J Kuehnle
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 252-255;

L

  1. Leighton, H J

    1. Quantitative assessment of the pre- and postsynaptic alpha adrenoceptor antagonist potency of amitriptyline.
      H J Leighton
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 299-304;

  2. Lietman, P S

    1. Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C.
      J J Lipsky and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 287-292;

  3. Linscheer, W G

    1. Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat.
      K L Raheja, W G Linscheer, C Cho and D Mahany
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 427-432;

  4. Lipsky, J J

    1. Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C.
      J J Lipsky and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 287-292;

  5. Little, S A

    1. Specific inhibition of calcium channels by calcium ions in smooth muscle.
      L Hurwitz, L J McGuffee, P M Smith and S A Little
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 382-388;

  6. Luft, F C

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

M

  1. Mahany, D

    1. Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat.
      K L Raheja, W G Linscheer, C Cho and D Mahany
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 427-432;

  2. McGuffee, L J

    1. Specific inhibition of calcium channels by calcium ions in smooth muscle.
      L Hurwitz, L J McGuffee, P M Smith and S A Little
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 382-388;

  3. McKenzie, R C

    1. Diethylstilbestrol: placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat.
      R K Miller, M E Heckmann and R C McKenzie
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 358-365;

  4. Mello, N K

    1. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
      J H Mendelson, J Ellingboe, N K Mello and J Kuehnle
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 252-255;

  5. Mendelson, J H

    1. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
      J H Mendelson, J Ellingboe, N K Mello and J Kuehnle
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 252-255;

  6. Miller, R K

    1. Diethylstilbestrol: placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat.
      R K Miller, M E Heckmann and R C McKenzie
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 358-365;

N

  1. Nader, H B

    1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
      P Bianchini, B Osima, B Parma, H B Nader and C P Dietrich
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 406-410;

  2. Nies, A S

    1. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins.
      M L Skoglund, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 371-374;

  3. Nomura, Y

    1. Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol.
      Y Nomura, H Kajiyama and T Segawa
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 411-416;

O

  1. Osima, B

    1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
      P Bianchini, B Osima, B Parma, H B Nader and C P Dietrich
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 406-410;

P

  1. Pace-Asciak, C

    1. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.
      E S Ferdinandi, M N Cayen and C Pace-Asciak
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 417-426;

  2. Parma, B

    1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
      P Bianchini, B Osima, B Parma, H B Nader and C P Dietrich
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 406-410;

  3. Peterson, C M

    1. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
      N F Tabachnik, P Blackburn, C M Peterson and A Cerami
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 243-246;

  4. Pitha, J

    1. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
      S P Baker and J Pitha
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 247-251;

  5. Prasad, C M

    1. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
      C M Prasad, S W Adamski, E Svensjö and G J Grega
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 293-298;

R

  1. Raheja, K L

    1. Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat.
      K L Raheja, W G Linscheer, C Cho and D Mahany
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 427-432;

  2. Rutledge, C O

    1. Developmental changes in the accumulation of norepinephrine and the chronotropic effects of catecholamines in isolated rat atria as influenced by dietary lipid.
      L C Wince and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 340-346;

S

  1. Segawa, T

    1. Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol.
      Y Nomura, H Kajiyama and T Segawa
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 411-416;

  2. Sender, M

    1. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
      G W Gullikson, M Sender and P Bass
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 236-242;

  3. Sherman, S

    1. Characterization of vasopressin analgesia.
      B A Berkowitz and S Sherman
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 329-334;

  4. Skoglund, M L

    1. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins.
      M L Skoglund, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 371-374;

  5. Smith, P M

    1. Specific inhibition of calcium channels by calcium ions in smooth muscle.
      L Hurwitz, L J McGuffee, P M Smith and S A Little
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 382-388;

  6. Snow, A E

    1. Interaction of apomorphine and stressors in the production of hyperthermia in the rabbit.
      A E Snow and A Horita
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 335-339;

  7. Stier, C T

    1. Effects of bromocriptine on single nephron and whole-kidney function in rats.
      C T Stier, E A Cowden and M E Allison
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 366-370;

  8. Svensjö, E

    1. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
      C M Prasad, S W Adamski, E Svensjö and G J Grega
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 293-298;

T

  1. Tabachnik, N F

    1. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
      N F Tabachnik, P Blackburn, C M Peterson and A Cerami
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 243-246;

V

  1. Verburg, M

    1. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
      W Bothwell, M Verburg, M Wynalda, E G Daniels and F A Fitzpatrick
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 229-235;

W

  1. Watkins, J B

    1. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
      J B Watkins and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 305-310;

  2. Weinberger, M H

    1. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
      F C Luft, G R Aronoff, A P Evan, B A Connors, M H Weinberger and S A Kleit
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 433-439;

  3. Wilcox, T K

    1. The effects of serotonin antagonists on the inhibition of primate spinothalamic tract cells produced by stimulation in nucleus raphe magnus or periaqueductal gray.
      R P Yezierski, T K Wilcox and W D Willis
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 266-277;

  4. Williams, N

    1. The effect of acute opioid administration on the phosphorylation of rat striatal synaptic membrane proteins.
      N Williams and D H Clouet
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 278-286;

  5. Willis, W D

    1. The effects of serotonin antagonists on the inhibition of primate spinothalamic tract cells produced by stimulation in nucleus raphe magnus or periaqueductal gray.
      R P Yezierski, T K Wilcox and W D Willis
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 266-277;

  6. Wince, L C

    1. Developmental changes in the accumulation of norepinephrine and the chronotropic effects of catecholamines in isolated rat atria as influenced by dietary lipid.
      L C Wince and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 340-346;

  7. Wynalda, M

    1. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
      W Bothwell, M Verburg, M Wynalda, E G Daniels and F A Fitzpatrick
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 229-235;

Y

  1. Yaksh, T L

    1. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
      J R Howe and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 311-321;

  2. Yezierski, R P

    1. The effects of serotonin antagonists on the inhibition of primate spinothalamic tract cells produced by stimulation in nucleus raphe magnus or periaqueductal gray.
      R P Yezierski, T K Wilcox and W D Willis
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 266-277;

Z

  1. Zipes, D P

    1. Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.
      V Elharrar and D P Zipes
      Journal of Pharmacology and Experimental Therapeutics February 1982, 220 (2) 440-447;
Back to top

In this issue

Advertisement